ArticleClinical, cosmetic and investigational dermatology2026
Differential Clinical Signatures of Vulvar Lichen Sclerosus, Lichen Planus, and Chronic Lichen Simplex: A Comparative Study in 1355 Patients.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vulvar lichen sclerosus (VLS), vulvar lichen planus (VLP), and vulvar lichen simplex chronicus (VLSC) are inflammatory dermatoses with overlapping clinical features, posing diagnostic challenges. VLS and VLP carry malignant potential, unlike VLSC. Comparative studies are limited despite frequent misclassification. Objective: To compare the clinical characteristics of VLS, VLP, and VLSC and identify distinguishing diagnostic features. Methods: A retrospective study was conducted on clinical data from patients diagnosed with VLS, VLP, or VLSC at the Beijing Hospital Vulvar Clinic (March 2017-August 2024). Epidemiological data, symptoms, and physical findings were compared. Results: Patients with VLP had a significantly higher median onset age (44 years) than VLS (30 years) or VLSC (34 years) ( Conclusion: VLS, VLP, and VLSC exhibit distinct differences in age of onset, clinical manifestations, lesion morphology, and anatomical distribution despite clinical overlap. Recognizing these features facilitates accurate diagnosis, guides individualized treatment, improves long-term outcomes, and enables early detection of malignant potential in VLS/VLP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.